Detalhe da pesquisa
1.
The academic point-of-care anti-CD19 chimeric antigen receptor T-cell product varnimcabtagene autoleucel (ARI-0001 cells) shows efficacy and safety in the treatment of relapsed/refractory B-cell non-Hodgkin lymphoma.
Br J Haematol
; 204(2): 525-533, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37905734
2.
Academic challenges on advanced therapy medicinal products' development: a regulatory perspective.
Cytotherapy
; 26(3): 221-230, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38260921
3.
Fractionated initial infusion and booster dose of ARI0002h, a humanised, BCMA-directed CAR T-cell therapy, for patients with relapsed or refractory multiple myeloma (CARTBCMA-HCB-01): a single-arm, multicentre, academic pilot study.
Lancet Oncol
; 24(8): 913-924, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37414060
4.
CART19-BE-01: A Multicenter Trial of ARI-0001 Cell Therapy in Patients with CD19+ Relapsed/Refractory Malignancies.
Mol Ther
; 29(2): 636-644, 2021 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33010231
5.
Add-on inhaled budesonide in the treatment of hospitalised patients with COVID-19: a randomised clinical trial.
Eur Respir J
; 59(3)2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35144989
6.
Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma.
Clin Cancer Res
; 30(10): 2085-2096, 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38466644
7.
Real-world effectiveness of caplacizumab vs the standard of care in immune thrombotic thrombocytopenic purpura.
Blood Adv
; 6(24): 6219-6227, 2022 12 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35930694
8.
Phase II randomised trial of autologous tumour lysate dendritic cell plus best supportive care compared with best supportive care in pre-treated advanced colorectal cancer patients.
Eur J Cancer
; 64: 167-74, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27428073
9.
Factors associated with the clinical outcome of patients with relapsed/refractory CD19+ acute lymphoblastic leukemia treated with ARI-0001 CART19-cell therapy.
J Immunother Cancer
; 9(12)2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34907029
10.
A polypill strategy to improve adherence: results from the FOCUS project.
J Am Coll Cardiol
; 64(20): 2071-82, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25193393
11.
TET2 mutations are associated with specific 5-methylcytosine and 5-hydroxymethylcytosine profiles in patients with chronic myelomonocytic leukemia.
PLoS One
; 7(2): e31605, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22328940
12.
[Thrombosis and antithrombotic therapy in the elderly]. / Trombosis y fármacos antitrombóticos en el anciano.
Med Clin (Barc)
; 137(10): 468-71, 2011 Oct 15.
Artigo
em Espanhol
| MEDLINE | ID: mdl-21752408
13.
Trombosis y fármacos antitrombóticos en el anciano / Thrombosis and antithrombotic therapy in the elderly
Med. clín (Ed. impr.)
; 137(10): 468-471, oct. 2011.
Artigo
em Espanhol
| IBECS (Espanha) | ID: ibc-91922